Portland State University

PDXScholar
OHSU-PSU School of Public Health Faculty
Publications and Presentations

OHSU-PSU School of Public Health

2020

Annual Wellness Visits and Influenza Vaccinations
among Older Adults in the US
Terese Sara Hoj Jørgensen
Oregon Health & Science University

Heather G. Allore
Yale University

Miriam R. Elman
OHSU-PSU School of Public Health

Corey L. Nagel
University of Arkansas for Medical Sciences

Mengran Zhang
Yale School of Medicine

See next page for additional authors
Follow this and additional works at: https://pdxscholar.library.pdx.edu/sph_facpub
Part of the Community Health Commons

Let us know how access to this document benefits you.
Citation Details
Jørgensen, T. S. H., Allore, H., Elman, M. R., Nagel, C., Zhang, M., Markwardt, S., & Quiñones, A. R. (2020).
Annual Wellness Visits and Influenza Vaccinations among Older Adults in the US. Journal of Primary Care
& Community Health, 11, 2150132720962870.

This Article is brought to you for free and open access. It has been accepted for inclusion in OHSU-PSU School of
Public Health Faculty Publications and Presentations by an authorized administrator of PDXScholar. Please contact
us if we can make this document more accessible: pdxscholar@pdx.edu.

Authors
Terese Sara Hoj Jørgensen, Heather G. Allore, Miriam R. Elman, Corey L. Nagel, Mengran Zhang, Sheila
Markwardt, and Ana R. Quiñones

This article is available at PDXScholar: https://pdxscholar.library.pdx.edu/sph_facpub/399

962870

research-article2020

JPCXXX10.1177/2150132720962870Journal of Primary Care & Community HealthJørgensen et al

Original Research

Annual Wellness Visits and Influenza
Vaccinations among Older Adults in
the US

Journal of Primary Care & Community Health
Volume 11: 1–10
© The Author(s) 2020
Article reuse guidelines:
sagepub.com/journals-permissions
https://doi.org/10.1177/2150132720962870
DOI: 10.1177/2150132720962870
journals.sagepub.com/home/jpc

Terese Sara Høj Jørgensen1 , Heather Allore2,3, Miriam R. Elman4,
Corey Nagel5, Mengran Zhang2, Sheila Markwardt4,
and Ana R. Quiñones1

Abstract
Objectives: Investigate whether combinations of sociodemographic factors, chronic conditions, and other health indicators
pose barriers for older adults to access Annual Wellness Visits (AWVs) and influenza vaccinations. Methods: Data on
4999 individuals aged ≥65 years from the 2012 wave of the Health and Retirement Study linked with Medicare claims were
analyzed. Conditional Inference Tree (CIT) and Random Forest (CIRF) analyses identified the most important predictors
of AWVs and influenza vaccinations. Multivariable logistic regression (MLR) was used to quantify the associations. Results:
Two-year uptake was 22.8% for AWVs and 65.9% for influenza vaccinations. For AWVs, geographical region and wealth
emerged as the most important predictors. For influenza vaccinations, number of somatic conditions, race/ethnicity,
education, and wealth were the most important predictors. Conclusions: The importance of geographic region for AWV
utilization suggests that this service was unequally adopted. Non-Hispanic black participants and/or those with functional
limitations were less likely to receive influenza vaccination.
Keywords
annual wellness visits, influenza vaccinations, preventive healthcare utilization, machine learning methods
Dates received 8 June 2020; revised 6 September 2020; accepted 10 September 2020.

Introduction
Aging of populations worldwide has intensified the focus on
appropriate receipt of preventive health services for the promotion of good health and wellbeing in old age.1-3 With the
increasing prevalence of older adults living with multiple
chronic conditions in the US,4,5 access to medical care and
supportive environments is essential to ensure health and
quality of life for these older adults.3 It is, thus, worrisome
from a public health perspective that recommended preventive healthcare services are substantially underutilized among
older adults in the US.6 To improve health and access to care
for this segment of the population, Annual Wellness Visits
(AWVs) offered at no cost for eligible Medicare beneficiaries
were introduced in 2011. The primary aim of this initiative
was to increase access to preventive healthcare services for
older adults.7,8 Influenza vaccination is a critical part of these
services as it is a high-impact and cost-effective strategy to
maintain the health of older adults.9 Following the introduction of AWVs, studies have elucidated favorable developments including increased referrals and use of preventive

healthcare services.10-17 At the same time, primary care physician practices and geographical regions where AWVs are
more frequently adopted do not deliver a higher amount of
healthcare services overall.18
Despite a gradual increase in utilization of AWVs after
their introduction in 2011,17-21 less than a quarter of Medicare
beneficiaries received an AWV in 2015.19 Previous studies
have identified underutilization of AWVs among older adults
who are unmarried, members of a race/ethnic minority group,
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or living in rural or less affluent areas.11,18,20,21 For influenza
vaccinations, while findings are inconsistent with regard to
age, sex, and single chronic conditions,11,18,21 sociodemographic factors and number of chronic conditions have been
consistently linked to influenza vaccination uptake among
older adults in the US.15,22-27
None of the previous studies on AWVs and influenza
vaccinations have focused on the interaction between individual characteristics, such as sociodemographic factors
and health indicators. However, individual characteristics
may converge to influence the receipt of AWVs and influenza vaccinations among Medicare beneficiaries. Better
understanding of the relationship between these factors in
the use of AWVs and influenza vaccinations will inform
future prevention efforts to address potential inequities and
barriers to accessing services among different demographic
groups. This study was undertaken to explore the combinations of sociodemographic factors, chronic conditions, and
other health indicators that characterize utilization of AWVs
and influenza vaccinations among groups of older adults.

Methods
We used data from the 2012 wave of the Health and
Retirement Study (HRS) linked through individual identification numbers with Centers for Medicare and Medicaid
Services (CMS) claims. In brief, the HRS is a nationally
representative survey of individuals aged ≥51 years. The
survey has been conducted biennially since 1992 with
refreshment samples added every 6 years.28 The selection of
participants (N = 4999) for the study was based on enrollment in Medicare Part A and B for 12 consecutive months
during the study period or until death, age ≥65 years, and
complete information for predictors (Figure A1). At least
3 years of enrollment in the Medicare fee-for-service program was required to identify the conditions based on the
Center for Medicare and Medicaid Services’ Chronic
Condition Data Warehouse (CCW) algorithms. The study
protocol was approved by Oregon Health and Science
University Institutional Review Board (STUDY00017034).
The main exposure variables consist of sociodemographic factors, chronic conditions, and other health indicators. Sociodemographic factors were identified in HRS and
include: age categorized as 65 to 69 years (reference) with
5-year increments to ≥90 years; sex (male as reference);
race/ethnicity categorized as non-Hispanic White (reference), Hispanic, and non-Hispanic Black; geographical
region based on Census Divisions: New England (reference), Mid-Atlantic, East-North Central, West-North
Central, South Atlantic, East-South Central, West-South
Central, Mountain Division, and Pacific Division (see
Online Appendix Figure A2 for more details); HRS validated measure of self-reported wealth (See Hurd et al for
further details29) included as quintiles in US$ (1st: ≤4000
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(reference), 2nd: >4000 to ≤150 000, 3rd: >150 000 to
≤327 500, 4th: >327 500 to ≤767 000, 5th:> 767 000);
Medicare-Medicaid dual eligibility (no as reference); and
education as years in school centered on 12 years (median).
Chronic conditions up to the time of HRS interview covered common chronic conditions in older adult populations
as recommended by Goodman et al.30 The chronic conditions
were identified from linked Medicare beneficiary files and
administrative claims using CMS Chronic Condition Data
Warehouse (CCW) algorithms.31,32 A description of the methodology to ascertain each chronic condition can be found at
the CCW website.31,32 Number of somatic conditions up until
the time of the HRS interview was defined as a count of
hypertension; congestive heart failure; coronary artery disease, coronary and ischemic heart disease; cardiac arrhythmias; hyperlipidemia; stroke; arthritis; asthma; cancer
(breast, prostate, lung, colorectal, blood and endometrial);
chronic kidney disease; chronic obstructive pulmonary disease; diabetes mellitus; and osteoporosis. Alzheimer’s disease and related disorders of senile dementia (ADRD) and
depression were included separately to address the presence
of mental or neurodegenerative conditions. Additional health
indicators from HRS included: activities of daily living and
instrumental activities of daily living (ADL/IADL) limitations by a continuous score (0-11) (ADL: dressing, walking
across a room, bathing, eating, getting in and out of bed, toileting; IADL: preparing hot meals, grocery shopping, using
telephone, taking medication, and managing money); body
mass index (BMI) categorized as underweight/normal: ≤25
(reference), overweight: >25-30, obese grade I: >30-35,
obese grade II: >35-40, obese grade III: ≥40; and proxy
interview (no proxy/self-interview as reference).
The two outcomes were identified by Current Procedural
Terminology (CPT) codes in CMS during 2-years followup from HRS interview date: (1) AWVs (CPT codes: G0438
and G0439) and (2) influenza vaccinations (CPT codes
90630, 90653–90657, 90661, 90662, 90672–90674, 90685–
90688, Q2035–Q2039, and G0008).17 AWVs and influenza
vaccinations were formulated as dichotomous variables.
Descriptive statistics were conducted using means with
standard deviations for continuous variables and frequencies with percentages for categorical variables for each of
the outcomes. Statistical analyses were conducted in 3
steps. First, Conditional Inference Tree (CIT) analyses,
implemented in the R package ‘partykit’,33 were performed
to identify combinations of sociodemographic factors,
chronic conditions, and other health indicators predicting
AWVs and influenza vaccinations. CIT is a non-parametric
machine learning method that performs recursive binary
partitioning to examine the relationship between multiple
explanatory variables and a single outcome. In this process,
a decision tree is constructed by testing the null hypothesis
of independence between each variable and the outcome. If
the hypothesis cannot be rejected or no division can be
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made without at least 60 individuals (1.2% of our sample)
in each group, the algorithm was stopped. Otherwise, the
variable with the greatest reduction of heterogeneity in the
outcome is selected and a binary split of the variable is performed. The algorithm recursively repeats these steps until
the stopping criteria are met. To build these models, we
used 75% of the dataset for training and reserved 25% for
testing. After constructing a CIT with the training data, we
used the test dataset to identified the accuracy, sensitivity,
and specificity of the CIT based on the cutoff point on the
ROC curve closest to the optimal model based on Youden’s
Index, the cutpoint on the ROC curve that optimizes both
sensitivity and specificity. We repeated the analyses three
times with different random seeds to confirm the robustness
of the results. Second, a Conditional Inference Random
Forest (CIRF) algorithm was implemented using the R
package ‘party’34 on the full dataset to test whether the CIT
identified the most important variables for predicting the
outcomes. This method uses bootstrapping aggregation to
create multiple decision trees, each using a random sample
of variables as split candidates, and collects their results.
Each forest was created using 1500 trees. We reported the
ranking of the variable importance identified in the CIRF
analyses. Third, multivariable logistic regression analyses
were conducted using the full dataset to identify risk estimates (adjusted odds ratios [aORs]) and 95% confidence
intervals (95% CI) and quantify the association between all
exposure variables and each of the two outcomes.
In the machine learning models, all count and continuous variables (age, educational level, BMI, ADL/IADL, and
wealth) were included as continuous variables. The previously described variable categorizations were used in the
logistic regression analyses. R code to run CIT and CIRF
are provided in the Online Appendix.

Results
Baseline characteristics for the overall population as well as
stratifications by AWV and influenza vaccination status are
presented in Table 1. In total, 1139 (22.8%) older adults
received an AWV and 3292 (65.8%) an influenza
vaccination.
Figure 1A shows results from the CIT analysis of AWVs
during the 2-year period following participants’ HRS interview. It shows that combinations of geographical region,
wealth, and education resulted in different proportions of
AWV utilization. Individuals living in New England had the
highest AWV utilization level of 40.4%. In the other geographical regions, individuals with ≤14 years of education
and wealth ≤$159 000 had the lowest AVW utilization of
15.2%. The CIT for this analysis had an accuracy of 55.4%
with a sensitivity of 52.8% and specificity of 56.2% in the
testing data. Repeating the Conditional Inference Tree analyses with different seeds produced CIT that all selected
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geographical region, wealth and education, but with different splits resulting in slightly different CIT structures. One
CIT additionally included age and another included ADL/
IADL limitations.
The CIRF results for AWVs are shown in Figure 2A.
They support findings from the CIT analyses, identifying
geographical region and wealth as the two most important
predictors of AWVs.
Multivariable logistic regression results (Table 2)
showed that relative to those living in New England, older
adults living in all other regions had lower ORs of receiving
AWVs. Residents in West-North Central (aOR: 0.32; 95%
CI: 0.22, 0.45), West-South Central (aOR: 0.35; 95%CI:
0.24, 0.49), and Mid-Atlantic (aOR: 0.38; 0.26, 0.54) were
associated with the lowest AWV utilization. A doseresponse relationship was identified between quintiles of
wealth and AWV utilization. Female sex, Hispanic ethnicity, and more years of education were also significantly
associated with higher ORs of AWV utilization in the multivariable logistic regression analysis. The concordance statistic (C-statistic) for the multivariable logistic regression
was 0.62.
Findings from the CIT analysis for receipt of influenza
vaccinations during the 2-year period after HRS interview
are presented in Figure 1B. These results show that various
combinations of race/ethnicity, number of somatic conditions, educational level and partnership status differentially
affected influenza vaccination uptake. The lowest levels of
influenza vaccination uptake were among (1) Hispanic and
non-Hispanic Black beneficiaries with ≤4 somatic conditions (42.1%) and (2) non-Hispanic White beneficiaries
with ≤2 somatic conditions and no partner (43.8%). The
highest level of influenza vaccination uptake was among
non-Hispanic White beneficiaries with >9 somatic conditions (84.4%). The CIT had an accuracy of 64.4% with a
sensitivity of 75.3% and a specificity of 43.2%. Repeating
the CIT analysis with different seeds produced trees that
selected the variables race/ethnicity, number of somatic
conditions, and education yet with different splits. None of
the other CIT included partnership status and one additionally incorporated ADL/IADL limitations.
The CIRF results for influenza vaccinations are shown in
Figure 2B. As we found in CIT analyses, number of somatic
conditions, race/ethnicity, educational level, and wealth
were identified as the most important predictors of influenza vaccination uptake. In addition, the CIRF analysis
identified partnership status as the 5th most important
predictor.
Multivariable logistic regression results (Table 2)
showed a dose-response relationship for somatic conditions (aOR: 1.19; 95%CI: 1.15, 1.22), years of education
(aOR: 1.06; 95%CI: 1.03, 1.08), and wealth in quintiles.
Non-Hispanic Black beneficiaries (aOR: 0.53; 95%CI:
0.44, 0.65 and aOR: 0.51; 95%CI: 0.37, 0.70) had lower
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Table 1. Baseline Characteristics of Study Population, n (%).
Annual wellness visits

All
Sociodemographic factors
Age
65-69 years
70-74 years
75-79 years
80-84 years
85-89 years
90+ years
Sex
Male
Female
Race/Ethnicity
Non-Hispanic white
Hispanic
Non-Hispanic black
Partnership status
No
Yes
Geographical region
New England
Mid-Atlantic
East-North Central
West-North Central
South Atlantic
East-South Central
West-South Central
Mountain division
Pacific division
Education in years, mean (SD)
Wealth
1st quintile
2nd quintile
3rd quintile
4th quintile
5th quintile
Dual eligibility
No
Yes
Chronic conditions
Somatic conditions, mean (SD)
Alzheimer’s disease
No
Yes
Depression
No
Yes
Other health indicators
Body mass index
Underweight/normal
Overweight
Obese grade 1
Obese grade 2
Obese grade 3
ADL/IADL limitations, mean (SD)
Proxy interview
No
Yes

Influenza vaccinations

All

No

Yes

No

Yes

4999 (100.0%)

3860 (77.2%)

1139 (22.8%)

1707 (34.1%)

3292 (65.9%)

746 (14.9%)
1371 (27.4%)
1298 (26.0%)
840 (16.8%)
488 (9.8%)
256 (5.1%)
1982 (39.6%)
3017 (60.4%)
4080 (81.6%)
314 (6.3%)
605 (12.1%)
2157 (43.1%)
2842 (56.9%)
218 (4.4%)
473 (9.5%)
855 (17.1%)
550 (11.0%)
1281 (25.6%)
352 (7.0%)
612 (12.2%)
225 (4.5%)
433 (8.7%)
12.6 (3.2)
1000 (20.0%)
1000 (20.0%)
1000 (20.0%)
1000 (20.0%)
999 (20.0%)
4468 (89.4%)
531 (10.6%)

564 (14.6%)
1027 (26.6%)
999 (25.9%)
667 (17.3%)
390 (10.1%)
213 (5.5%)
1542 (39.9%)
2318 (60.1%)
3115 (80.7%)
242 (6.3%)
503 (13.0%)
1723 (44.6%)
2137 (55.4%)
133 (3.4%)
381 (9.9%)
662 (17.2%)
455 (11.8%)
987 (25.6%)
249 (6.5%)
502 (13.0%)
168 (4.4%)
323 (8.4%)
12.4 (3.2)
845 (21.9%)
803 (20.8%)
766 (19.8%)
746 (19.3%)
700 (18.1%)
3426 (88.8%)
434 (11.2%)

182 (16.0%)
344 (30.2%)
299 (26.3%)
173 (15.2%)
98 (8.6%)
43 (3.8%)
440 (38.6%)
699 (61.4%)
965 (84.7%)
72 (6.3%)
102 (9.0%)
434 (38.1%)
705 (61.9%)
85 (7.5%)
92 (8.1%)
193 (16.9%)
95 (8.3%)
294 (25.8%)
103 (9.0%)
110 (9.7%)
57 (5.0%)
110 (9.7%)
13.0 (3.1)
155 (13.6%)
197 (17.3%)
234 (20.5%)
254 (22.3%)
299 (26.3%)
1042 (91.5%)
97 (8.5%)

273 (16.0%)
480 (28.1%)
457 (26.8%)
265 (15.5%)
146 (8.6%)
86 (5.0%)
700 (41.0%)
1007 (59.0%)
1271 (74.5%)
127 (7.4%)
309 (18.1%)
793 (46.5%)
914 (53.5%)
63 (3.7%)
140 (8.2%)
320 (18.7%)
185 (10.8%)
442 (25.9%)
104 (6.1%)
221 (12.9%)
78 (4.6%)
154 (9.0%)
12.1 (3.3)
427 (25.0%)
394 (23.1%)
329 (19.3%)
283 (16.6%)
274 (16.1%)
1487 (87.1%)
220 (12.9%)

473 (14.4%)
891 (27.1%)
841 (25.5%)
575 (17.5%)
342 (10.4%)
170 (5.2%)
1282 (38.9%)
2010 (61.1%)
2809 (85.3%)
187 (5.7%)
296 (9.0%)
1364 (41.4%)
1928 (58.6%)
155 (4.7%)
333 (10.1%)
535 (16.3%)
365 (11.1%)
839 (25.5%)
248 (7.5%)
391 (11.9%)
147 (4.5%)
279 (8.5%)
12.8 (3.1)
573 (17.4%)
606 (18.4%)
671 (20.4%)
717 (21.8%)
725(22.0%)
2981 (90.6%)
311 (9.4%)

5.3 (2.5)
4188 (83.8%)
811 (16.2%)
3393 (67.9%)
1606 (32.1%)

5.3 (2.5)
3208 (83.1%)
652 (16.9%)
2612 (67.7%)
1248 (32.3%)

5.2 (2.5)
4.7 (2.5)
980 (86.0%) 1,464 (85.8%)
159 (14.0%)
243 (14.2%)
781 (68.6%) 1222 (71.6%)
358 (31.4%)
485 (28.4%)

5.5 (2.5)
2724 (82.7%)
568 (17.3%)
2171 (65.9%)
1121 (34.1%)

1868 (37.4%)
1812 (36.2%)
885 (17.7%)
307 (6.1%)
127 (2.5%)
0.8 (1.9)
4793 (95.9%)
206 (4.1%)

1432 (37.1%)
1385 (35.9%)
696 (18.0%)
249 (6.5%)
98 (2.5%)
0.8 (1.9)
3691 (95.6%)
169 (4.4%)

436 (38.3%)
427 (37.5%)
189 (16.6%)
58 (5.1%)
29 (2.5%)
0.6 (1.7)
1102 (96.8%)
37 (3.2%)

623 (36.5%)
604 (35.4%)
333 (19.5%)
104 (6.1%)
43 (2.5%)
0.8 (2.0)
1631 (95.5%)
76 (4.5%)

1245 (37.8%)
1208 (36.7%)
552 (16.8%)
203 (6.2%)
84 (2.6%)
0.7 (1.8)
3162 (96.1%)
130 (3.9%)
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Figure 1. Conditional Inference Trees for (A) Annual Wellness Visits (AWV) and (B) Influenza vaccinations (Flu). Explanatory note:
The circles (child nodes) show the characteristics (variables) for which the data is split into the final boxes (terminal nodes). The
boxes show the proportion of individuals with these characteristics that receive (A) Annual Wellness Visits (AWV) and (B) Influenza
vaccinations (Flu). The “n”s under the boxes provide the number of individuals in each terminal node.

adjusted odds of influenza vaccinations than non-Hispanic
White and Hispanic beneficiaries, respectively. Influenza
vaccination uptake did not vary between non-Hispanic
White and Hispanic beneficiaries. Older adults with a

partner had 19% (95% CI: 1.19, 1.37) higher odds of influenza vaccinations than those without. Female sex and
ADL/IADL limitations were also significantly associated
with higher adjusted odds of influenza vaccinations. The

6

Figure 2. Conditional Inference Random Forest for (A) Annual
Wellness Visits and (B) Influenza vaccinations. Explanatory
note: The graphs illustrate the ranking of variable importance
for predictors on the y-axis. The x-axis shows the mean
decrease in accuracy if the specific variable is removed from a
Conditional Inference Tree. The ranking of the variables are
informative, whereas the variable importance value should not
be interpreted.35

C-statistic for the multivariable logistic regression was
0.66.

Discussion
We conducted machine learning analyses to explore combinations of predictors for AWVs and influenza vaccinations
among US Medicare beneficiaries. The most important predictors of receiving an AWV were geographical region and
wealth, whereas number of somatic conditions, race/ethnicity, educational level, and wealth were the most important
predictors of influenza vaccinations.
Utilization of AWVs has increased since its introduction
in 2011.17-21 In this study, 22.8% received at least one AWV
within a 2-year period following their 2012 HRS interview,
which is comparable to previous findings in a 5% national
sample of Medicare beneficiaries in 2011 to 2013.14
However, a recent report has shown that AWV uptake for
Medical Advantage patients increased from 2011 to 2015,
leading to 40% greater uptake in these patients compared to
fee-for-service patients.36 Furthermore, another study found
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that healthcare practices with medically and socially complex patients provide less AWVs, whereas accountable Care
Organizations and practices with higher rates of electronic
health record incentive program participation provided
more AWVs in 2015.19 Yet, future studies are needed to
determine whether the increase in AWVs since their introduction is explained by diffusion of recommendations from
practice guidelines and policy to implementation in the
healthcare practices and/or by incentives programs aimed at
managed care beneficiaries.
We identified individuals living in New England to have
the highest AWV utilization. Interestingly, we identified
that no other characteristics were predictive of utilization
within this region in the CIT analysis. For individuals living
in the other geographical regions, AWV utilization was
lowest among beneficiaries with fewer years of education
(≤14) and lower levels of wealth (≤$159 000). This illustrates that individual socioeconomic factors, which are
related to uptake of other preventive healthcare like influenza vaccination,24 may be important in geographical
regions with lower AWV utilization. To ensure adequate
provision and use of preventive services, it is essential that
AWVs are equally available and accessible across all geographical regions of the country. When this is met, our findings suggest that socioeconomic factors may be important
for utilization.
Our finding that geographical region is the most important predictor of AWVs with highest utilization in New
England is supported by a study of a 20% random sample of
2015 Medicare beneficiaries. Ganguli et al. (2018) showed
that 51.2% of primary care practices did not provide AWVs;
those that provided AWVs were clustered in the Northeast
and urban areas, had a more stable patient assignment and a
slightly healthier patient mix. Practices with lower AWV
rates more often provided care for underserved populations,
such as racial minorities and Medicare-Medicaid dual eligibility patients.19 We also identified that socioeconomic factors including wealth and education were important
predictors of AWV utilization. This is indirectly supported
in a number of other studies that identified residence in
more affluent areas and non-rural metropolitan areas to
have higher AWV utilization.11,18,20,21
Hispanic ethnicity and female sex were significantly
associated with greater AWV utilization in the multivariable
logistic regression analysis. Previous studies of sex are
inconsistent.11,21 Studies have shown lower AWV utilization
among non-Hispanic Black and other race/ethnicity groups
compared to non-Hispanic White Medicare beneficiaries.11,18,20,21 One study that investigated utilization among
Hispanic beneficiaries found lower utilization of AWVs in
comparison to non-Hispanic White beneficiaries in univariable analysis, but no association in multivariable analysis.20
The surprising finding from our analysis that AWV utilization was higher in Hispanic beneficiaries compared to
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Table 2. Multivariable Logistic Regression Analyses of Annual Wellness Visits and Influenza Vaccinations.
Odds ratio (95% confidence interval)*
Sociodemographic factors
Age

Sex
Race/Ethnicity**

Partnership status
Geographical region

Education in years
Wealth

Medicaid-Medicare dual eligibility
Chronic conditions
Number of Somatic conditions
Alzheimer’s disease
Depression
Other health indicators
Body mass index

ADL/IADL limitations
Proxy interview

Annual wellness visits
65-69 years
70-74 years
75-79 years
80-84 years
85-89 years
90+ years
Male
Female
Non-Hispanic white
Hispanic
Non-Hispanic black
No
Yes
New England
Mid-Atlantic
East-North Central
West-North Central
South Atlantic
East-South Central
West-South Central
Mountain division
Pacific division

Influenza vaccinations

1st quintile
2nd quintile
3rd quintile
4th quintile
5th quintile
No
Yes

1.00 (reference)
1.04 (0.84;1.29)
0.93 (0.74;1.16)
0.77 (0.59;0.99)
0.78 (0.57;1.06)
0.70 (0.46;1.04)
1.00 (reference)
1.20 (1.03;1.39)
1.00 (reference)
1.58 (1.14;2.18)
0.87 (0.68;1.11)
1.00 (reference)
1.11 (0.95;1.30)
1.00 (reference)
0.38 (0.26;0.54)
0.47 (0.34;0.65)
0.32 (0.22;0.45)
0.47 (0.34;0.64)
0.67 (0.47;0.97)
0.35 (0.24;0.49)
0.48 (0.32;0.72)
0.48 (0.34;0.69)
1.04 (1.01;1.06)
1.00 (reference)
1.36 (1.07;1.74)
1.62 (1.27;2.09)
1.71 (1.33;2.22)
2.11 (1.62;2.75)
1.00 (reference)
1.07 (0.81;1.40)

1.00 (reference)
0.95 (0.79;1.16)
0.86 (0.70;1.06)
0.89 (0.70;1.12)
0.96 (0.73;1.27)
0.86 (0.61;1.21)
1.00 (reference)
1.28 (1.12;1.46)
1.00 (reference)
1.04 (0.78;1.39)
0.53 (0.44;0.65)
1.00 (reference)
1.19 (1.03;1.37)
1.00 (reference)
0.94 (0.65;1.35)
0.72 (0.51;0.99)
0.82 (0.57;1.16)
0.85 (0.61;1.17)
1.14 (0.77;1.67)
0.85 (0.59;1.20)
0.74 (0.49;1.12)
0.69 (0.48;0.99)
1.06 (1.03;1.08)
1.00 (reference)
1.11 (0.92;1.35)
1.35 (1.09;1.66)
1.66 (1.33;2.07)
1.67 (1.33;2.10)
1.00 (reference)
1.10 (0.88;1.37)

No
Yes
No
Yes

1.03 (0.99;1.06)
1.00 (reference)
0.94 (0.75;1.16)
1.00 (reference)
1.02 (0.87; 1.19)

1.19 (1.15;1.22)
1.00 (reference)
1.11 (0.92;1.35)
1.00 (reference)
1.11 (0.96;1.28)

1.00 (reference)
1.02 (0.87;1.20)
0.89 (0.73;1.09)
0.79 (0.57;1.08)
1.05 (0.66;1.62)
0.97 (0.93;1.02)
1.00 (reference)
1.02 (0.67;1.51)

1.00 (reference)
1.05 (0.91;1.21)
0.87 (0.72;1.04)
1.05 (0.80;1.39)
0.97 (0.65;1.46)
0.95 (0.91;0.99)
1.00 (reference)
1.12 (0.80;1.58)

Normal
Overweight
Obese grade 1
Obese grade 2
Obese grade 3
No
Yes

*Bold = statistical significant estimates.
**Odds ratio and 95% confidence interval for non-Hispanic black vs. Hispanic: Annual Wellness Visits 0.55 (0.38, 0.80) and influenza vaccinations
0.51 (0.37, 0.70).

non-Hispanic White and Black beneficiaries may not be
representative of the full Medicare population. Our study
only had 6.3% Hispanics, whereas Hispanics represented
10.7% of the population in the previous study.20 Hispanic

particpants in the present study may be a more selected
group and, thus, possibly healthier than the general Hispanic
population in the US, because they represent a smaller proportion of the final study population compared to other
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studies. This may be explained by the strict selection criteria (Figure A1), which may have influenced the inclusion of
this race/ethnic group more than non-Hispanic white and
black participants.
This study elucidated that AWVs do not reach all
Americans and utilization was especially low among beneficiaries with lower levels of wealth and education in geographical regions with overall low AWV utilization. This
could lead to unforeseen negative consequences by increasing sociodemographic health disparities among older adults
in the US. Due to the risk of increased health disparities,
Tipirneni et al suggest implementation of a new version of
AWVs that targets the root causes of poor health covering
individual, social, and behavioral determinants of health in
addition to addressing cognition, balance, and vision as predictors of poor health.37 Our findings and those from previous studies suggest that a first step to increase access to and
use of AWVs may be to increase incentives for healthcare
providers throughout the US to administer AWVs.
Influenza vaccination coverage of 65.9% during the
2-year period in this study is in line with coverage
(66.2% ± 0.8%) among adults aged ≥65 years in the US
during the 2012-2013 season.38
We identified number of somatic conditions, race/ethnicity, educational level, and wealth as important predictors of
influenza vaccination uptake. Uptake was highest among
non-Hispanic White beneficiaries with >9 somatic conditions. By contrast, influenza vaccination uptake was low
among all race/ethnic groups with few somatic conditions
– that is, non-Hispanic White beneficiaries with ≤2 somatic
conditions and no partner and Hispanic and non-Hispanic
Black beneficiaries with ≤3 somatic conditions. This may
suggest an interplay between somatic conditions and race/
ethnicity for influenza vaccination coverage.
Previous studies have also identified chronic conditions
as positive predictors of influenza vaccination uptake in the
US;26 however, findings for single chronic conditions such
as dementia, diabetes, and asthma are inconsistent.22,25,26 In
this study, neither ADRD nor depression were identified as
predictors of influenza vaccinations. Individuals with medical conditions are at the highest risk of complications
including death from influenza infections;39 hence, it is an
important and positive public health finding that older
adults with more somatic conditions have greater uptake.
In our multivariable logistic regression, we found that
non-Hispanic Black beneficiaries had lower influenza vaccination uptake than both non-Hispanic White and Hispanic
beneficiaries. Influenza vaccination, surprisingly, did not
differ between non-Hispanic White and Hispanic beneficiaries, which may be explained by a healthy selection of
Hispanics in our study population as previously discussed.
Prior studies generally showed lower influenza vaccination
uptake among race/ethnic minorities in the US. Two studies
have shown that non-Hispanic Black and/or Hispanic older

Journal of Primary Care & Community Health 
adults had lower uptake than non-Hispanic White older
adults,15,23 and one study showed that non-Hispanic Black
older adults more often refused influenza vaccination than
non-Hispanic White older adults.27 However, a fourth study
showed that Hispanics had the lowest uptake of racial/ethnic groups examined and were less aware of recommendations, less informed about influenza virus and benefits of
vaccination, and the least confident about the vaccine compared to both non-Hispanic Black and White older adults.22
Lower influenza vaccination uptake in minority groups may
be explained by differences in community-specific attitudes
toward vaccination, inadequate access to care, marginalization, and lack of trust in the healthcare system.24 The impact
of sex on influenza vaccination coverage is mixed,15,25,27
whereas Medicare-Medicaid dual eligible beneficiaries
have been found to have lower coverage.15
A number of literature reviews have proposed mechanisms that may lead to underutilization of influenza vaccinations. In summary, a positive attitude toward influenza
vaccination, high perceived utility and safety of vaccination, previous severe influenza experiences, cues to action
including advice from health professionals and kin networks, habits (e.g., previous influenza vaccination uptake),
and practical barriers including transport and access issues
for the oldest older adults were identified as the major and
most consistent factors influencing influenza vaccination
uptake.24,40-42 The largest of the systematic reviews (N = 470
studies) argued that sociodemographic factors are only indirectly related to influenza vaccination utilization.41
Our findings and those from previous studies show a
continued need for the healthcare system and public health
authorities to strive toward greater influenza vaccination
coverage among older adults in the US. This is supported by
a qualitative meta-analysis of 14 years of influenza-related
communication research by U.S. Centers for Disease
Control and Prevention (CDC). The qualitative meta-analysis showed that many people have an aversion toward influenza vaccinations and tend to overestimate the effect of
other actions to decrease the risk of infection with influenza
virus.42 Further, the positive impact of AWVs on preventive
healthcare utilization10-17 may suggest that increased implementation of AWVs throughout the US may help improve
influenza vaccination uptake.
This study has several strengths. Through linkage of
HRS and CMS, we were able to identify a comprehensive
number of potential predictors of AWVs and influenza
vaccinations including sociodemographic characteristics,
chronic conditions, and other health indicators. We
included information on chronic conditions and use of
preventive healthcare services from CMS, which are not
subject to recall bias. We were able to explore our research
questions and the impact of multiple predictors by leveraging machine learning models instead of restricting our
hypothesis to a priori knowledge. In CIT analyses, we
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obtained empirical information about the combinations of
variables important for AWV utilization and influenza
vaccination uptake, not restricted to a linear relationship.
The differences in the two analytical approaches (logistic
regression models versus machine learning models)
resulted in slightly different findings, which is reasonable
due to the different criteria for the two analytical
approaches. The logistic regression model is a parametric
model that builds on a specific form and estimates parameters based on the data. The logistic regression model is
defined and the effects of the variables are quantified
from the fitted data. On the other hand, the machine learning methods make predictions based on the data where
there are no assumptions about specific functional forms
or inferential models. Instead, an algorithm is presented
with the training inputs and desired outputs and executes
all steps to develop a rule to map inputs to outputs. These
machine learning methods provide automated ways of
assessing complex data for important patterns. In this
study, the machine learning methods were applied to
identify key predictors of the two outcomes, whereas the
logistic regression model was used to quantify the
relationships.
The generalizability of our results to all older Americans
may be hampered by restricting the study population to
Medicare FFS beneficiaries aged ≥65 years with ≥3 years
of enrollment in the Medicare fee-for-service program at
baseline. This was necessary to identify chronic conditions
by the CCW algorithms31,32 and subsequent preventive
healthcare use (Figure A1). There were also insufficient
numbers of American Indian/Native Alaskan or Asians in
HRS to include in the models, limiting inference for these
groups. Although these approaches provide insights to factors associated with AWV and influenza vaccination, they
do not infer a causal relationship. Finally, the study did not
elucidate potential mediating factors explaining the sociodemographic factors and morbidities as predictors of AWVs
and influenza vaccination. Especially, healthcare utilization
may be an important factor explaining the findings, which
should be investigated in future studies.

Conclusion
AWVs and influenza vaccinations are underutilized
among the US Medicare population. Applying CIT and
CIRF analyses, we identified geographical region and
wealth as important factors for AWV utilization, whereas
number of somatic conditions, race/ethnicity, wealth and
educational level were predictive for influenza vaccination uptake. The importance of geographic region for
AWV utilization suggests that this service was unequally
adopted. Non-Hispanic black participants and/or those
with functional limitations were less likely to receive
influenza vaccination.
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